Final patient dosed in Phase 2 stroke trial
Dosing of patients in Argenica Therapeutics’ Phase 2 clinical trial of the neuroprotective drug ARG-007 in acute ischaemic stroke has...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
The clinic, led by Dr. Jan Ho, provides comprehensive care alongside a team of nursing and allied health professionals. Services include post-rehabilitation assessments and ongoing management of stroke-related disabilities, such as language, mobility, and cognitive challenges, as well as pain, spasticity, and seizures. Clinic patients suitable for emerging restorative neurology programs may also be able to participate.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.